Oral sildenafil ameliorates impaired pulmonary circulation early after bidirectional cavopulmonary shunt.

[1]  M. Schwaiblmair,et al.  Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension. , 2004, Chest.

[2]  T. Nakanishi,et al.  Effect of beraprost sodium on pulmonary vascular resistance in candidates for a Fontan procedure: a preliminary study. , 2003 .

[3]  C. Brizard,et al.  Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery , 2003, Intensive Care Medicine.

[4]  G. Butrous,et al.  Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart Disease , 2003, Circulation.

[5]  R. Kloner,et al.  Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular disease. , 2003, Circulation.

[6]  J. Deanfield,et al.  Basal Pulmonary Vascular Resistance and Nitric Oxide Responsiveness Late After Fontan-Type Operation , 2003, Circulation.

[7]  W. Mahle,et al.  Endothelial function following the Fontan operation. , 2003, The American journal of cardiology.

[8]  C. Danel,et al.  Nitric oxide synthase expression by pulmonary arteries: a predictive marker of Fontan procedure outcome? , 2003, The Journal of thoracic and cardiovascular surgery.

[9]  T. Miyamoto,et al.  Combined therapy with inhaled nitric oxide and intravenous epoprostenol (prostacyclin) for critical pulmonary perfusion after the Fontan procedure. , 2003, The Journal of thoracic and cardiovascular surgery.

[10]  A. Atz,et al.  Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises. , 2002, The Journal of thoracic and cardiovascular surgery.

[11]  K. Sørensen,et al.  Pulmonary endothelial dysfunction after cardiopulmonary bypass in neonatal pigs , 2002, Acta anaesthesiologica Scandinavica.

[12]  M. Sakuma,et al.  Hemodynamic effects of inhaled nitric oxide using pulse delivery and continuous delivery systems in pulmonary hypertension. , 2002, Internal medicine.

[13]  L. Shekerdemian,et al.  Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. , 2002, American journal of respiratory and critical care medicine.

[14]  E. Schmid,et al.  Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery. , 1999, Anesthesia and analgesia.

[15]  A. Atz,et al.  Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. , 1999, Anesthesiology.

[16]  J Burnett,et al.  Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. , 1997, The Journal of thoracic and cardiovascular surgery.

[17]  A. Atz,et al.  Rebound pulmonary hypertension after inhalation of nitric oxide. , 1996, The Annals of thoracic surgery.

[18]  G. Buckberg,et al.  Pulmonary vasoconstriction due to impaired nitric oxide production after cardiopulmonary bypass. , 1996, The Annals of thoracic surgery.

[19]  A. Weaver,et al.  The modified Fontan operation. An analysis of risk factors for early postoperative death or takedown in 702 consecutive patients from one institution. , 1995, The Journal of thoracic and cardiovascular surgery.

[20]  Y. Takanashi,et al.  A new method for the quantitative standardization of cross-sectional areas of the pulmonary arteries in congenital heart diseases with decreased pulmonary blood flow. , 1984, The Journal of thoracic and cardiovascular surgery.